-
1 Comment
Paul Hartmann AG is currently in a long term downtrend where the price is trading 1.1% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
Paul Hartmann AG's total revenue sank by 0.0% to $560M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.
Finally, its free cash flow grew by 150.9% to $61M since the same quarter in the previous year.
Based on the above factors, Paul Hartmann AG gets an overall score of 2/5.
CurrencyCode | EUR |
---|---|
Exchange | F |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
ISIN | DE0007474041 |
Target Price | None |
---|---|
Dividend Yield | 3.5% |
Beta | 0.52 |
Market Cap | 820M |
PE Ratio | 10.07 |
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, contact layers, absorption pads, cotton, and negative pressure wound therapy; compression, universal, zinc, and padding bandages; and hands, skin, surface, instruments, and equipment disinfection and hygiene products. In addition, the company sells operating theater products, including surgical drapes, operating theater clothing, surgical gloves, surgical absorbents and instruments; various Mediset products; parent care products, such as hygiene and maternity products, examination gloves, and nursing care products; diagnostics, such as blood pressure monitors, scale, and thermometers; first aid products; and cotton buds. It sells its products under the CombiSet, MoliCare, Sterillium, Veroval, and Zetuvit brands. The company was founded in 1818 and is headquartered in Heidenheim, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PHH2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025